Company Filing History:
Years Active: 1992-1997
Title: Christopher G Rudman: Innovator in Bone Growth Technology
Introduction
Christopher G Rudman is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of bone growth technology, holding a total of 4 patents. His work focuses on innovative methods for inducing bone growth, which have important implications for medical treatments.
Latest Patents
Rudman's latest patents include a method of inducing bone growth using TGF-.beta. This method provides a way to generate bone at a site where skeletal tissue is deficient. It involves administering a composition comprising TGF-.beta. in a pharmaceutically acceptable carrier, along with a source of osteogenic cells. The composition is specifically designed to exclude a bone morphogenetic cofactor. Additionally, he has developed a device for implantation at deficient skeletal sites, treated with an effective amount of TGF-.beta. and osteogenic cells.
Career Highlights
Christopher G Rudman is associated with Genentech, Inc., a leading biotechnology company. His work at Genentech has allowed him to focus on groundbreaking research and development in the field of bone regeneration. His innovative approaches have the potential to transform treatment options for patients with skeletal deficiencies.
Collaborations
Rudman has collaborated with notable colleagues such as Arthur J Ammann and Theodore J Hahn. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Christopher G Rudman is a pioneering inventor whose work in bone growth technology is making a significant impact in the medical field. His innovative methods and collaborations continue to push the boundaries of what is possible in regenerative medicine.